Odevixibat
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Progressive Familial Intrahepatic Cholestasis
Conditions
Progressive Familial Intrahepatic Cholestasis
Trial Timeline
— → —
NCT ID
NCT04483531About Odevixibat
Odevixibat is a pre-clinical stage product being developed by Ipsen for Progressive Familial Intrahepatic Cholestasis. The current trial status is completed. This product is registered under clinical trial identifier NCT04483531. Target conditions include Progressive Familial Intrahepatic Cholestasis.
What happened to similar drugs?
2 of 20 similar drugs in Progressive Familial Intrahepatic Cholestasis were approved
Approved (2) Terminated (4) Active (14)
Hype Score Breakdown
Clinical
3
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04483531 | Pre-clinical | Completed |
| NCT05426733 | Phase 3 | Recruiting |
| NCT05035030 | Phase 3 | Recruiting |
Competing Products
20 competing products in Progressive Familial Intrahepatic Cholestasis